Cadila Healthcare Limited Hydroxychloroquine Export Data — India (DGFT 2022–2026)

Name: Cadila Healthcare Limited Hydroxychloroquine Export Records India — #3 Exporter, 40 Shipments, $2.0M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Hydroxychloroquine

India Pharmaceutical Trade Intelligence

$141.5M163 Suppliers86 CountriesHS 30049099

ExportsIndia → UNITED STATES89.2%India → UNITED KINGDOM1.9%

ImportsUNITED STATES → India$9.0K THAILAND → India$1.5K

#1 Supplier: ZYDUS LIFESCIENCES #1 Buyer: EVERSANA LIFE

Cadila Healthcare Limited — Hydroxychloroquine Exporter #3 | $2.7M Trade Value | TransData Nexus | TransData Nexus

Cadila Healthcare Limited — Hydroxychloroquine Exporter Profile

Indian Pharmaceutical Exporter · #3 for Hydroxychloroquine · $2.7M export value · DGFT Verified

Cadila Healthcare Limited is the #3 Indian exporter of Hydroxychloroquine with $2.7M in export value and 40 verified shipments. Cadila Healthcare Limited holds a 1.4% market share in Hydroxychloroquine exports across 5 countries. The company exports 41 pharmaceutical products worth $34.9M across 17 therapeutic categories.

Cadila Healthcare Limited — Hydroxychloroquine Export Profile: Buyers & Destinations

Cadila Healthcare Limited Hydroxychloroquine export treemap — buyers and destination countries | TransData Nexus

Where Does Cadila Healthcare Limited Export Hydroxychloroquine?

Country	Value	Shipments	Share
UNITED STATES	$1.9M	39	75.5%
THAILAND	$288.7K	7	11.2%
VIETNAM	$250.0K	5	9.7%
HONG KONG	$50.0K	1

Who Are the Top Buyers of Hydroxychloroquine from Cadila Healthcare Limited?

Buyer	Country	Value	Orders
EVERSANA LIFE SCIENCE SERVICES	UNITED STATES	$1.8M	36
KASPA PHARMACEUTICAL THAILAND	THAILAND	$179.8K	4
HAPHARCOJ S CBRANCH	VIETNAM	$100.0K	2
NORTHSTAR DISTRIBUTION CENTER	UNITED STATES	$100.0K	2
HAPHARCO J S C BRANCH CHI MINH CITY	VIETNAM	$100.0K	2
KASPA PHARMACEUTICAL THAILAND CO LTD	THAILAND	$79.8K	2
HAPHARCO J S C BRANCH	VIETNAM	$50.0K	1
PRIORITY HEALTHCARE DISTRIBUTION DB	UNITED STATES	$50.0K	1
CHEMILL PHARMA LIMITED	HONG KONG	$50.0K	1
SUNSHINE HEALTHCARE LANKA LIMITED	SRI LANKA	$35.5K	1

Cadila Healthcare Limited supplies Hydroxychloroquine to 12 buyers globally. The largest buyer is EVERSANA LIFE SCIENCE SERVICES (UNITED STATES), followed by KASPA PHARMACEUTICAL THAILAND (THAILAND) and HAPHARCOJ S CBRANCH (VIETNAM). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Hydroxychloroquine Formulations Does Cadila Healthcare Limited Export?

Product Description / Formulation	Value	Shipments
PHARMA : HYDROXYCHLOROQUINE SULFATE TABL	$450.0K	9
HYDROXYCHLOROQUINE SULFATE TABLETS USP 2	$200.0K	4
HYDROXYCHLOROQUINE SULFATE TABLETS USP 200MG [1X100 PER PACK]	$200.0K	4
HCQ HYDROXYCHLOROQUINE SULPHATE USP 200MG 10 X 10'S	$200.0K	4
ZYQUENIL HYDROXYCHLOROQUINE SULFATE TAB	$158.9K	4
HYDROXYCHLOROQUINE SULFATE TABLETS USP 200MG DIST. NDC - 68382-096-01 MANUFACTURING . NDC -65841-633-01 AS PER INVOICE. & P.LIST	$150.0K	3
HYDROXYCHLOROQUINE SULFATE TABLETS USP 200MG 1X100T	$150.0K	3
HYDROXYCHLOROQUINE SULFATE TABLETS USP 200MG [1X500 PER PACK]	$150.0K	3
HYDROXYCHLOROQUINE SULFATE TABLETS USP 200MG	$100.0K	2
ZYQUENIL HYDROXYCHLOROQUINE SULFATE TABS USP 200MG 10 X 10T	$79.8K	2

Cadila Healthcare Limited exports 26 distinct Hydroxychloroquine formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PHARMA : HYDROXYCHLOROQUINE SULFATE TABL with 9 shipments worth $450.0K.

How Does Cadila Healthcare Limited Compare to Nearest Hydroxychloroquine Exporters?

Exporters ranked immediately above and below #3 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	ZYDUS LIFESCIENCES LIMITED	$12.9M	259	8	$50.0K
2	IPCA LABORATORIES LIMITED	$7.3M	146	11	$50.0K
3	CADILA HEALTHCARE LIMITED ★	$2.0M	40	5	$50.0K
5	INTAS PHARMACEUTICALS LIMITED	$1.1M	21	3	$50.0K
4	CADILA HEALTHCARE LTD	$700.0K	14	4	$50.0K

Cadila Healthcare Limited ranks #3 among 163 Indian Hydroxychloroquine exporters. Average shipment value of $50.0K compared to the market average of $159.2K. The closest competitors by value are ZYDUS LIFESCIENCES LIMITED and IPCA LABORATORIES LIMITED.

Which Indian Ports Ship Hydroxychloroquine Exports?

Port	Shipments	% Share
SAHAR AIR CARGO ACC (INBOM4)	935	25.2%
SAHAR AIR	756	20.3%
DELHI AIR CARGO ACC (INDEL4)	610	16.4%
DELHI AIR	305	8.2%
Bombay Air	285	7.7%
MUNDRA SEA	137	3.7%
Delhi Air	116	3.1%
NHAVA SHEVA SEA (INNSA1)	76	2.0%

Geopolitical & Trade Policy Impact on Cadila Healthcare Limited's Hydroxychloroquine Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Zydus. The escalating conflict in the Middle East has disrupted key maritime routes, particularly the Red Sea and Suez Canal, leading to longer transit times and increased freight costs. Major carriers have suspended or restricted transits, extending transit times by 10–20 days and raising freight rates by 40–50% on key India–Europe routes. (livemint.com) This situation poses significant challenges for time-sensitive pharmaceutical shipments, especially temperature-sensitive medicines. (economictimes.indiatimes.com)

Conversely, U.S.–China trade tensions have prompted the U.S. to impose tariffs on Chinese pharmaceutical imports, creating an opportunity for Indian exporters to fill the supply gap. However, the U.S. has also introduced tariffs on Indian imports, including a 25% "reciprocal" tariff, followed by an additional 25% penalty tied to India's continued imports of Russian oil, bringing the total duty to 50%. (en.wikipedia.org) While pharmaceuticals are currently exempt, the potential for future tariffs necessitates strategic planning.

In the European Union, compliance with the Falsified Medicines Directive (FMD) is crucial. The FMD mandates stringent serialization and traceability requirements to prevent counterfeit medicines from entering the supply chain. Non-compliance can result in restricted market access, making adherence to these regulations imperative for exporters like Zydus.

Cadila Healthcare Limited — Regulatory Compliance & Quality Standards

Maintaining compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. The U.S. FDA, WHO, and EU Good Manufacturing Practice (GMP) guidelines set stringent quality benchmarks. Any lapses can lead to import alerts, product recalls, or facility shutdowns. For instance, in 2019, Zydus's Moraiya facility received an Official Action Indicated (OAI) classification from the U.S. FDA, indicating that regulatory and/or administrative actions were recommended. (moneycontrol.com) Such events underscore the importance of robust quality assurance systems.

The evolving regulatory landscape demands continuous investment in compliance infrastructure. The EU's Falsified Medicines Directive and the U.S. Drug Supply Chain Security Act (DSCSA) require advanced serialization and traceability measures. Non-compliance can result in restricted market access, making adherence to these regulations imperative for exporters like Zydus.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Hydroxychloroquine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Cadila Healthcare Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 54 individual customs records matching Cadila Healthcare Limited exporting Hydroxychloroquine, covering 26 formulations to 6 countries via 12 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 86+ countries, 271+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Hydroxychloroquine

Hydroxychloroquine

Cadila Healthcare Limited — Hydroxychloroquine Exporter Profile

Cadila Healthcare Limited — Hydroxychloroquine Export Profile: Buyers & Destinations

Where Does Cadila Healthcare Limited Export Hydroxychloroquine?

Who Are the Top Buyers of Hydroxychloroquine from Cadila Healthcare Limited?

What Is India's Total Hydroxychloroquine Export Value and How Much Does Cadila Healthcare Limited Contribute?

What Is the Average Shipment Value for Cadila Healthcare Limited's Hydroxychloroquine Exports?

How Does Cadila Healthcare Limited Compare to Other Indian Hydroxychloroquine Exporters?

What Hydroxychloroquine Formulations Does Cadila Healthcare Limited Export?

Regulatory Requirements: Exporting Hydroxychloroquine to Key Markets

United States — FDA

How Does Cadila Healthcare Limited Compare to Nearest Hydroxychloroquine Exporters?

Which Indian Ports Ship Hydroxychloroquine Exports?

What Other Antimalarial & Antiparasitic Products Does Cadila Healthcare Limited Export?

Geopolitical & Trade Policy Impact on Cadila Healthcare Limited's Hydroxychloroquine Exports

Cadila Healthcare Limited — Regulatory Compliance & Quality Standards

About Cadila Healthcare Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Hydroxychloroquine Export Data from Cadila Healthcare Limited

Hydroxychloroquine Stats

Company Overview

Top Products by Cadila Healthcare Limited

Related Analysis

Need Detailed Export Data?

Data Source